Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 210, 177-184
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81600018)
- Joint Research Fund for International Cooperation (519600-X11601)
This publication has 59 references indexed in Scilit:
- The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical PracticeInternational Journal of Molecular Sciences, 2013
- COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONSDepression and Anxiety, 2013
- Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label studyNeuropsychiatric Disease and Treatment, 2013
- Anhedonia and major depression: The role of agomelatineEuropean Neuropsychopharmacology, 2012
- Synergistic mechanisms involved in the antidepressant effects of agomelatineEuropean Neuropsychopharmacology, 2012
- Serum BDNF levels before treatment predict SSRI response in depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Memory facilitating effects of agomelatine in the novel object recognition memory paradigm in the ratPharmacology Biochemistry and Behavior, 2011
- Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in ratsBrain Research, 2011
- Effect of agomelatine and its interaction with the daily corticosterone rhythm on progenitor cell proliferation in the dentate gyrus of the adult ratNeuropharmacology, 2010
- Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathwaysBMC Neuroscience, 2010